(postbulletin.com): Paul Scott in his monthly column recently suggested that The Mayo Clinic Proceedings is currently used as a platform for drug companies. He challenged some of the policies of the current editor, and berated Merck pharmaceuticals for distributing a PhRMA favorable editorial to health care professionals. The author disagrees with Mr. Scott's analysis and commentary, and would like to suggest that we actually need to encourage and maintain interaction between academic researchers, medical journals, and the pharmaceutical industry for the advancement of medical science. All sponsored medical research should not be confused with marketing. Most physicians would agree that Innovative, relevant pharmaceutical research should be published and debated in peer-reviewed medical journals in the interest of medical science.
Category: Articles
Click here